IPO activity at its lowest in Europe since the global financial crisis
Association for Financial Markets in Europe has released its latest Equity Primary Markets and Trading Report
ANNOUNCEMENT: Expert Investor is now PA Europe. Read more.
Association for Financial Markets in Europe has released its latest Equity Primary Markets and Trading Report
Fund managers discuss where they are finding the most attractively-valued stocks Since Warren Buffett got involved, the world has gone crazy for Japan. The Nikkei is up 23.4% for the year to date (to 10 July 2023). That puts it 8.8%, 11.2% and 25.8% ahead of the S&P 500, Eurostoxx 50 and FTSE 100 respectively.…
While the market can famously remain irrational longer than investors can remain solvent, analysis suggests this growth rally is thinly supported Having largely given up on organic intelligence, investors have grown all excited over its artificial offspring. As a result, the (mainly US) stocks linked to AI have raced away from the broad market this…
2022 was hailed a year of revival for value strategies, but they have been comprehensively outpaced by growth strategies to date in 2023. The MSCI World Growth index has beaten the MSCI World Value index by around 14% since the start of the year, with weaker commodity markets, economic weakness and the banking crisis all…
Value strategies have been comprehensively outpaced
Mutual fund and ETFs promoters saw respective inflows of €5bn and €11bn
At the annual Berkshire Hathaway meeting at the start of May, Warren Buffett sounded a gloomy note, warning that corporate earnings were likely to be lower as an ‘incredible period’ in American economic history drew to a close. He is not alone. There is an increasing gap between the optimism displayed by stock markets, and…
How investors in the biotech sector can benefit from artificial intelligence’s increasing importance in drug discovery and development purposes Artificial intelligence and machine-learning algorithms are disruptive technologies that are having a twofold impact on the drug discovery process. First, the technology can be applied to save time and money during the process of identifying molecular…
Gareth Blades on the differing attractions of the pioneers, enablers and adopters of genetic sequencing In one of my favourite childhood films, Jurassic Park, Dr Ian Malcolm – perfectly played by Jeff Goldblum – cautions that “genetic power’s the most awesome force the planet’s ever seen”. That was 30 years ago – and it is…
The ongoing volatility in the global banking sector has seen UBS take on Credit Suisse – a move likened around Europe to a ‘shotgun wedding’, with the role of the gun-toting parent being assumed by the Swiss government. Under the terms of the deal, the cumulative financial risk the general public is shouldering to save…
Blackrock report expects market to grow 11 fold in the next five years
Following a marked decline in public investment across the continent